Doctor profile · Federal record
Dr. Matthew Rowley, MD
Specialist (CMS: Dermatology) · Dermatology Physician · Lufkin, TX
- NPI 1871538702
- Accepts Medicare
- MIPS 89.0 / 100 · 2023
- 32 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
107 Christie Street
Lufkin, TX 759045575
(936) 634-9648
fax (936) 634-9663
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- June 13, 2016
- Year of graduation
- 1994 — 32 yrs since
- Specialty taxonomy
- 174400000X — NUCC code
- State license (1)
- Texas #J0235
- Medicaid
- TX #098766103
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1871538702. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
11,064
Distinct HCPCS
10
Medicare allowed
$1,202,491
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
G6001 |
Ultrasonic guidance for placement of radiation therapy fields | 1,628 | 103 | $169 | |
77280 |
Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 1,453 | 81 | $253 | |
77401 |
Superficial and/or low voltage radiation treatment delivery | 1,401 | 77 | $38 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,055 | 306 | $6 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 960 | 629 | $54 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 871 | 646 | $86 | |
17000 |
Destruction of precancer skin growth, 1 growth | 783 | 553 | $51 | |
17110 |
Destruction of skin growth, 1-14 growths | 441 | 364 | $103 | |
11102 |
Biopsy of related skin growth, first growth | 342 | 308 | $87 | |
77427 |
Radiation treatment management, 5 treatment sessions | 284 | 82 | $184 |
In context: peer comparison
Among 1 peers in Lufkin Specialist, average services per provider: 251. This provider delivers 44× the peer median.Open Payments
Industry payments received
All-time total
$1,643
Transactions
76
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 31 | $708.15 | |
| Janssen Biotech, INC. | 10 | $278.85 | |
| Lilly USA, LLC | 13 | $197.72 | |
| Genzyme Corporation | 6 | $121.29 | |
| Ucb, INC. | 3 | $87.08 | |
| Novartis Pharmaceuticals Corporation | 5 | $84.02 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $54.06 | |
| Amgen INC. | 2 | $48.02 | |
| Regeneron Healthcare Solutions, INC. | 1 | $26.58 | |
| Leo Pharma INC. | 1 | $19.14 | |
| Galderma Laboratories, L.P. | 1 | $18.35 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,275
Patients
764
Total drug cost
$44,589
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Imiquimod | Generic | 207 | 141 | $6,141 |
| Triamcinolone Acetonide | Generic | 140 | 90 | $1,689 |
| Fluorouracil | Generic | 139 | 130 | $15,284 |
| Ketoconazole | Generic | 139 | 75 | $2,906 |
| Doxycycline Hyclate | Generic | 133 | 52 | $5,737 |
| Betamethasone Dipropionate | Generic | 77 | 40 | $3,617 |
| Terbinafine Hcl | Generic | 58 | 32 | $951 |
| Methotrexate (Methotrexate Sodium) | Brand | 55 | 13 | $1,091 |
| Pentoxifylline | Generic | 55 | 17 | $1,164 |
| Prednisone | Generic | 51 | 25 | $323 |
Frequently asked questions
What is Dr. Matthew Rowley's medical specialty?
Dr. Matthew Rowley practices Specialist in Lufkin, TX.
Where does Dr. Matthew Rowley practice?
Dr. Matthew Rowley practices at 107 Christie Street, Lufkin, TX 759045575. Office phone: 9366349648.
What is Dr. Matthew Rowley's NPI?
Dr. Matthew Rowley's National Provider Identifier (NPI) is 1871538702, issued by NPPES.
Does Dr. Matthew Rowley accept Medicare assignment?
Yes. Dr. Matthew Rowley accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Matthew Rowley commonly perform?
Top Medicare-reported procedures in 2023: Ultrasonic guidance for placement of radiation therapy fields (HCPCS G6001); Obtaining data needed to develop the optimal radiation treatment, 1 treatment area (HCPCS 77280); Superficial and/or low voltage radiation treatment delivery (HCPCS 77401). Source: CMS Medicare Physician & Other Practitioners file.